Bio Essence Corp
BIOE· OTC
BIOEBio Essence Corp
Quarterly figures for Bio Essence Corp, with source filings when available.
26 quarters. Mar 31, 2020 to Jun 30, 2026. USD.
Bio Essence Corp has filed its 10-Q within 43 to 50 days of period end across its last 8 quarters. The 10-K runs 86 to 106 days.
Bio Essence Corp · CIK 1723059 · Engraved from SEC EDGAR
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Source trail |
|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | |||||||||
| Q2 2026 | Jun 30, 2026 | — | Aug 14, 2026 | 45 d | 10-Q | $794.71K | +206.7% | $0.00 | |
| Q1 2026 | Mar 31, 2026 | — | May 15, 2026 | 45 d | 10-Q | $500.54K | +2,155.8% | $0.00 | |
| FY 2025 | |||||||||
| Q4 2025derived | Dec 31, 2025 | — | Mar 27, 2026 | 86 d | 10-K | $1.48M | — | — | |
| Q3 2025 | Sep 30, 2025 | — | Nov 12, 2025 | ||||||
| FY 2024 | |||||||||
| Q4 2024derived | Dec 31, 2024 | — | Mar 28, 2025 | 87 d | 10-K | — | — | — | |
| Q3 2024 | Sep 30, 2024 | — | Nov 14, 2024 | 45 d | 10-Q | ||||
| FY 2023 | |||||||||
| Q4 2023derived | Dec 31, 2023 | — | Apr 15, 2024 | 106 d | 10-K | — | — | — | |
| Q3 2023 | Sep 30, 2023 | — | Nov 13, 2023 | 44 d | 10-Q | ||||
| FY 2022 | |||||||||
| Q4 2022derived | Dec 31, 2022 | — | Mar 30, 2023 | 89 d | 10-K | — | — | — | |
| Q3 2022 | Sep 30, 2022 | — | Nov 14, 2022 | 45 d | 10-Q | ||||
| FY 2021 | |||||||||
| Q4 2021derived | Dec 31, 2021 | — | Mar 31, 2022 | 90 d | 10-K | $213.04K | −2.7% | — | |
| Q3 2021 | Sep 30, 2021 | — | Nov 12, 2021 | ||||||
| FY 2020 | |||||||||
| Q4 2020derived | Dec 31, 2020 | — | Apr 14, 2021 | 104 d | 10-K | $218.93K | — | — | |
| Q3 2020 | Sep 30, 2020 | — | — | ||||||
| 43 d |
| 10-Q |
| $136.80K |
| +1.6% |
| $0.00 |
| Q2 2025 | Jun 30, 2025 | — | Aug 14, 2025 | 45 d | 10-Q | $259.12K | +521.5% | $0.00 |
|---|
| Q1 2025 | Mar 31, 2025 | — | May 15, 2025 | 45 d | 10-Q | $22.19K | — | -$0.01 |
|---|
| $134.69K |
| −13.5% |
| -$0.03 |
| Q2 2024 | Jun 30, 2024 | — | Aug 19, 2024 | 50 d | 10-Q | $41.70K | −83.9% | -$0.01 |
|---|
| Q1 2024 | Mar 31, 2024 | — | May 17, 2024 | 47 d | 10-Q | — | — | $0.00 |
|---|
| $155.70K |
| −18.9% |
| -$0.01 |
| Q2 2023 | Jun 30, 2023 | — | Aug 14, 2023 | 45 d | 10-Q | $259.57K | −9.9% | -$0.01 |
|---|
| Q1 2023 | Mar 31, 2023 | — | May 12, 2023 | 42 d | 10-Q | $341.33K | +11.4% | -$0.01 |
|---|
| $192.05K |
| −15.4% |
| -$0.01 |
| Q2 2022 | Jun 30, 2022 | — | Aug 15, 2022 | 46 d | 10-Q | $288.14K | +22.1% | $0.00 |
|---|
| Q1 2022 | Mar 31, 2022 | — | May 16, 2022 | 46 d | 10-Q | $306.41K | +44.5% | -$0.01 |
|---|
| 43 d |
| 10-Q |
| $226.99K |
| −0.6% |
| -$0.01 |
| Q2 2021 | Jun 30, 2021 | — | Aug 12, 2021 | 43 d | 10-Q | $235.93K | +15.0% | $0.00 |
|---|
| Q1 2021 | Mar 31, 2021 | — | May 11, 2021 | 41 d | 10-Q | $212.03K | −30.8% | -$0.01 |
|---|
| — |
| — |
| $228.33K |
| — |
| -$0.01 |
| Q2 2020 | Jun 30, 2020 | — | — | — | — | $205.09K | — | -$0.01 |
|---|
| Q1 2020 | Mar 31, 2020 | — | — | — | — | $306.35K | — | $0.00 |
|---|
